- Evidence of a personally signed and dated informed consent
- Subjects aged >=18 who have documented PAH
- Speak English
- Subjects who provide written informed consent to participate in the study before being
screened for the study.
- Patients with non-PAH Pulmonary Hypertension
- Physical inability to complete the interview process
- Subjects who are currently enrolled in an experimental drug study